• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: Epigenetic Regulation and Tumor Immunotherapy.社论：表观遗传调控与肿瘤免疫治疗
Front Oncol. 2022 May 5;12:893157. doi: 10.3389/fonc.2022.893157. eCollection 2022.
2
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.表观遗传修饰在癌症发展和进展中的抑制性免疫检查点中的作用。
Front Immunol. 2020 Jul 14;11:1469. doi: 10.3389/fimmu.2020.01469. eCollection 2020.
3
Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?免疫检查点的表观遗传调控：癌症免疫治疗的另一个靶点？
Immunotherapy. 2017 Jan;9(1):99-108. doi: 10.2217/imt-2016-0111.
4
The complex role of EZH2 in the tumor microenvironment: opportunities and challenges for immunotherapy combinations.EZH2 在肿瘤微环境中的复杂作用：免疫治疗联合的机遇与挑战。
Future Med Chem. 2020 Aug;12(15):1415-1430. doi: 10.4155/fmc-2020-0072. Epub 2020 Jul 29.
5
Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma.组蛋白乙酰化调控因子介导的乙酰化模式定义了肝细胞癌中的肿瘤恶性途径和肿瘤微环境。
Front Immunol. 2022 Jan 25;13:761046. doi: 10.3389/fimmu.2022.761046. eCollection 2022.
6
An update on colorectal cancer microenvironment, epigenetic and immunotherapy.结直肠癌微环境、表观遗传学和免疫治疗的最新进展。
Int Immunopharmacol. 2020 Dec;89(Pt A):107041. doi: 10.1016/j.intimp.2020.107041. Epub 2020 Oct 9.
7
EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy.EZH2，实体瘤微环境和免疫治疗的遗传与表观遗传调控的重要协调因子。
Biochim Biophys Acta Rev Cancer. 2022 Mar;1877(2):188700. doi: 10.1016/j.bbcan.2022.188700. Epub 2022 Feb 22.
8
Acetylation in Tumor Immune Evasion Regulation.肿瘤免疫逃逸调控中的乙酰化作用。
Front Pharmacol. 2021 Nov 22;12:771588. doi: 10.3389/fphar.2021.771588. eCollection 2021.
9
Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.表观遗传和转录控制的表皮生长因子受体调节胰腺癌的肿瘤免疫微环境。
Cancer Discov. 2021 Mar;11(3):736-753. doi: 10.1158/2159-8290.CD-20-0519. Epub 2020 Nov 6.
10
Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma.表观遗传调控增强肝癌的免疫治疗。
Cell Immunol. 2019 Feb;336:66-74. doi: 10.1016/j.cellimm.2018.12.010. Epub 2019 Jan 2.

引用本文的文献

1
Regulation of Granzymes A and B by High-Risk HPV: Impact on Immune Evasion and Carcinogenesis.高危型人乳头瘤病毒对颗粒酶A和颗粒酶B的调控：对免疫逃逸和致癌作用的影响
Viruses. 2025 Feb 3;17(2):221. doi: 10.3390/v17020221.
2
Dual activity of Minnelide chemosensitize basal/triple negative breast cancer stem cells and reprograms immunosuppressive tumor microenvironment.Minnelide 通过双重作用增敏基底/三阴性乳腺癌干细胞并重塑免疫抑制性肿瘤微环境。
Sci Rep. 2024 Sep 28;14(1):22487. doi: 10.1038/s41598-024-72989-6.
3
Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives.黑色素瘤免疫检查点免疫治疗反应的基因组和表观基因组生物标志物：现状和未来展望。
Int J Mol Sci. 2024 Jun 30;25(13):7252. doi: 10.3390/ijms25137252.
4
Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth.休眠样药物耐受持久态：涅槃重生的关键。
Medicina (Kaunas). 2024 Jan 28;60(2):228. doi: 10.3390/medicina60020228.
5
Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN.通过调控MYCN靶向作用于含溴结构域和额外末端结构域的蛋白质以抑制神经母细胞瘤的肿瘤发生
Front Cell Dev Biol. 2022 Sep 16;10:1021820. doi: 10.3389/fcell.2022.1021820. eCollection 2022.

本文引用的文献

1
EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma.EEF2K 沉默通过抑制 SPP1 抑制肿瘤进展，并与黑色素瘤中的 BET 抑制剂协同作用。
Clin Transl Med. 2022 Feb;12(2):e722. doi: 10.1002/ctm2.722.
2
The role of N6-methyladenosine mRNA in the tumor microenvironment.N6-甲基腺苷 mRNA 在肿瘤微环境中的作用。
Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188522. doi: 10.1016/j.bbcan.2021.188522. Epub 2021 Feb 2.
3
BET inhibitor suppresses melanoma progression the noncanonical NF-κB/SPP1 pathway.BET 抑制剂抑制黑色素瘤进展的非经典 NF-κB/SPP1 通路。
Theranostics. 2020 Sep 15;10(25):11428-11443. doi: 10.7150/thno.47432. eCollection 2020.
4
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.ALKBH5 通过调节肿瘤微环境中的乳酸和抑制性免疫细胞积累来调控抗 PD-1 治疗反应。
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20159-20170. doi: 10.1073/pnas.1918986117. Epub 2020 Aug 3.
5
Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses.表观遗传策略与PD-L1/PD-1靶向癌症免疫疗法协同作用，以增强抗肿瘤反应。
Acta Pharm Sin B. 2020 May;10(5):723-733. doi: 10.1016/j.apsb.2019.09.006. Epub 2019 Sep 25.
6
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction.强效 BRD4 抑制剂抑制癌细胞与巨噬细胞的相互作用。
Nat Commun. 2020 Apr 14;11(1):1833. doi: 10.1038/s41467-020-15290-0.
7
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells.N6-甲基腺苷调节 TGFβ1 的表达和分泌，影响癌细胞的上皮-间充质转化。
Cells. 2020 Jan 25;9(2):296. doi: 10.3390/cells9020296.
8
The emerging role of epigenetic therapeutics in immuno-oncology.表观遗传学治疗在肿瘤免疫治疗中的新兴作用。
Nat Rev Clin Oncol. 2020 Feb;17(2):75-90. doi: 10.1038/s41571-019-0266-5. Epub 2019 Sep 23.
9
The role of m6A RNA methylation in cancer.m6A RNA 甲基化在癌症中的作用。
Biomed Pharmacother. 2019 Apr;112:108613. doi: 10.1016/j.biopha.2019.108613. Epub 2019 Feb 19.
10
Functions and mechanisms of non-histone protein acetylation.非组蛋白蛋白乙酰化的功能和机制。
Nat Rev Mol Cell Biol. 2019 Mar;20(3):156-174. doi: 10.1038/s41580-018-0081-3.

Editorial: Epigenetic Regulation and Tumor Immunotherapy.

作者信息

Sun Hongyin, Huang Bihui, Cao Jian, Yan Qin, Yin Mingzhu

机构信息

Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China.

Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.

出版信息

Front Oncol. 2022 May 5;12:893157. doi: 10.3389/fonc.2022.893157. eCollection 2022.

DOI:10.3389/fonc.2022.893157
PMID:35600405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9117615/
Abstract
摘要